Technical Analysis for BJDX - Bluejay Diagnostics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Reached Overbought | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Wide Range Bar | Range Expansion | 6.17% | |
| Upper Bollinger Band Walk | Strength | 6.17% | |
| Wide Bands | Range Expansion | 6.17% | |
| Above Upper BB | Strength | 6.17% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 18 hours ago |
| Up 10% | about 20 hours ago |
| Up 5% | about 20 hours ago |
| 60 Minute Opening Range Breakout | about 21 hours ago |
| Up 3% | about 21 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 12/14/2023
Bluejay Diagnostics, Inc. Description
Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biotechnology Cancer Clinical Medicine Infectious Diseases Inflammation Allergy Biomarkers Allergic Conjunctivitis Chemical Pathology Congestive Heart Failure Sepsis Conjunctivitis Lyme Disease Tick Borne Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.28 |
| 52 Week Low | 0.0652 |
| Average Volume | 20,379,839 |
| 200-Day Moving Average | 2.67 |
| 50-Day Moving Average | 0.32 |
| 20-Day Moving Average | 0.60 |
| 10-Day Moving Average | 1.10 |
| Average True Range | 0.35 |
| RSI (14) | 86.36 |
| ADX | 45.5 |
| +DI | 72.57 |
| -DI | 3.07 |
| Chandelier Exit (Long, 3 ATRs) | 3.02 |
| Chandelier Exit (Short, 3 ATRs) | 1.12 |
| Upper Bollinger Bands | 3.02 |
| Lower Bollinger Band | -1.82 |
| Percent B (%b) | 1.09 |
| BandWidth | 804.23 |
| MACD Line | 0.62 |
| MACD Signal Line | 0.23 |
| MACD Histogram | 0.3936 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.16 | ||||
| Resistance 3 (R3) | 4.13 | 3.85 | 4.04 | ||
| Resistance 2 (R2) | 3.85 | 3.67 | 3.87 | 4.00 | |
| Resistance 1 (R1) | 3.65 | 3.56 | 3.75 | 3.68 | 3.96 |
| Pivot Point | 3.37 | 3.37 | 3.43 | 3.39 | 3.37 |
| Support 1 (S1) | 3.17 | 3.19 | 3.27 | 3.20 | 2.92 |
| Support 2 (S2) | 2.89 | 3.08 | 2.91 | 2.88 | |
| Support 3 (S3) | 2.69 | 2.89 | 2.84 | ||
| Support 4 (S4) | 2.72 |
